NASDAQ:PRCT

PRCT rises as Wall Street slips; investors look again at Aquablation
····

PRCT rises as Wall Street slips; investors look again at Aquablation

PROCEPT BioRobotics shares rose 0.6% to $28.29 in early Thursday trading, outperforming broader medical device stocks as Wall Street opened lower. The move follows the American Urological Association’s strengthened recommendation for Aquablation therapy. PROCEPT reported Q1 revenue of $83.1 million, up 20%, but posted a wider net loss of $31.6 million. The company reaffirmed 2026 revenue guidance of $390–$410 million.
May 21, 2026

Stock Market Today

  • Investing $5,000 Yearly in ASX Shares: Can It Build Wealth?
    May 28, 2026, 4:53 PM EDT. Investing $5,000 annually into ASX shares with an average 9% return, while not guaranteed, can grow significantly due to compounding - where earnings generate their own earnings. After 20 years, such investments could reach around $280,000, and after 30 years, approximately $740,000. At 34 years, the portfolio might surpass $1 million without increasing the annual contribution. Experts recommend a diversified approach, such as using ASX ETFs like Vanguard's MSCI Index International Shares ETF (ASX: VGS), combined with select quality stocks. The key is discipline, patience, and allowing time to harness compounding effects across market cycles.